What blood tests can indicate alcohol consumption?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most effective blood test to indicate alcohol consumption is Phosphatidylethanol (PEth) testing, which is highly specific for alcohol consumption and can detect use for up to 3-4 weeks, as supported by the most recent study in 2025 1. Several blood tests can indicate alcohol consumption, with the most common being liver function tests (LFTs) that measure enzymes like gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), and alanine aminotransferase (ALT). These enzymes become elevated when alcohol damages liver cells. For recent alcohol use, direct alcohol biomarkers include blood alcohol concentration (BAC), which detects alcohol in the bloodstream for about 12-24 hours after consumption, and ethyl glucuronide (EtG) and ethyl sulfate (EtS), which can be detected for up to 3-4 days. For chronic or long-term alcohol use, carbohydrate-deficient transferrin (CDT) is particularly useful as it remains elevated for approximately 2-4 weeks after heavy drinking stops. Mean corpuscular volume (MCV), which measures red blood cell size, can also increase with chronic alcohol use. These tests vary in sensitivity and specificity, with some like PEth and CDT being more specific to alcohol use, while liver enzymes can be elevated due to other conditions affecting the liver. It's essential to consider the limitations and potential confounding factors of each test, as well as the clinical context and patient history, when interpreting the results, as noted in studies from 2020 1 and 2018 1. The use of these biomarkers should be guided by clinical judgment and used in conjunction with other diagnostic tools, such as patient interviews and physical examinations, to provide a comprehensive assessment of alcohol consumption, as recommended by the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines in 2022 1. In clinical practice, a combination of these tests, including PEth, CDT, and LFTs, can be used to screen and monitor alcohol use, as outlined in the position statement by an expert panel on alcohol-related liver disease in 2025 1. Ultimately, the choice of test and interpretation of results should be individualized to each patient's unique circumstances and medical history.

From the Research

Blood Tests for Alcohol Consumption

Several blood tests can indicate alcohol consumption, including:

  • Blood alcohol concentration (BAC) 2
  • Gamma-glutamyl transferase (GGT) 2, 3, 4, 5
  • Carbohydrate-deficient transferrin (CDT) 2, 3, 4, 6, 5
  • Alanine aminotransferase (ALT) 2, 6
  • Aspartate aminotransferase (AST) 2, 6
  • Mean corpuscular volume (MCV) 2, 3, 6
  • Phosphatidylethanol (PEth) 2, 6

Sensitivity and Specificity of Blood Tests

The sensitivity and specificity of these blood tests vary, with:

  • CDT having a sensitivity of 67% and a specificity of 97% 3
  • GGT having a sensitivity of 42% and a specificity of 76% 3
  • MCV having a sensitivity of 24% and a specificity of 96% 3
  • PEth being a sensitive and specific marker of alcohol consumption, but its application is limited due to the costly equipment necessary for its measurement 2

Emerging Blood Biomarkers

Emerging blood biomarkers for alcohol consumption include:

  • Fatty acid ethyl ester (FAEE) 6
  • Total serum sialic acid (TSA) 6
  • Cholesteryl ester transfer protein (CETP) 6
  • N-Acetyl-β-Hexosaminidase (Beta-Hex) 6
  • Macrophage migration inhibitory factor (MIF) 6
  • D-dopachrome tautomerase (DDT) 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.